Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/4/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Timothy J. Triche

Wrong Dr. Timothy J. Triche?

Director of the Center for Person...

Childrens Hospital Los Angeles
4650 Sunset Blvd. MS#75
Los Angeles, California 90027
United States

Company Description: Founded in 1901, Childrens Hospital Los Angeles has been treating the most seriously ill and injured children in Los Angeles for more than a century, and it is...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • PhD
    Tulane Univeristy
  • BSc , Physics
    Cornell University
  • MD PhD Chief Medical Officer
  • MD/PhD
    University of Southern California
151 Total References
Web References
Tim Triche - Children's ...
realtimegenomics.com, 4 Mar 2014 [cached]
Tim Triche - Children's Hospital Los Angeles
Dr. Triche's research focuses on genetic aspects of cancer biology and their biologic consequences. He has been chair of the Department of Pathology & Laboratory Medicine and pathologist-in-chief at Children's Hospital Los Angeles, and vice chairman of the Department of Pathology and professor of pathology and pediatrics at the Keck School of Medicine since 1988. He also serves as the Chief Medical Officer at NanoValent Pharmaceuticals, Inc., and previously as the Chairman and Chief Executive Officer of Oncormed, Inc. He served as the Chief of the Ultrastructural Laboratory of the Division of Pathology at the National Cancer Institute of the National Institutes of Health. Previously, he was Chair of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles.
Dr. Triche sits on the advisory boards of several companies, including Baird Venture Patners, Insert Therapeutics, Inc., and Calando PHarmaceuticals, Inc. He serves as a director fo companies such as LTC Properties Inc., Oncor Inc. and Health Management Inc. He serves as tghe Chariman of the Board of Directors of Novelix Pharmaceuticals Inc., which he founded in 2005. Dr. Triche received an A.B. from Cornell University in 1966, and in 1971 received both a Ph.D. in cell biology and an M.D. from Tulane University.
Board of Directors | SV Bio
www.svbio.com, 22 Feb 2014 [cached]
Timothy Triche, M.D., Ph.D.,Professor of Pathology & Director, Center for Personalized Medicine, Children's Hospital Los Angeles
...
Timothy Triche, M.D., Ph.D.
Professor of Pathology & Director, Center for Personalized Medicine, Children's Hospital Los Angeles
Dr. Triche is a member of the Board of Directors of SVBio. His distinguished career as a physician and pathologist has been marked by pioneering work in the fields of cancer, genomics and the development of technologies that enable personalized medicine.
He currently serves as a professor of pathology and as the Director of the Center for Personalized Medicine at Children's Hospital Los Angeles. He also serves as the Chief Medical Officer at NanoValent Pharmaceuticals, Inc., and previously as the Chairman and Chief Executive Officer of Oncormed, Inc. He served as the Chief of the Ultrastructural Laboratory of the Division of Pathology at the National Cancer Institute of the National Institutes of Health. Previously, he was Chair of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles.
Dr. Triche sits on the advisory boards of several companies, including Baird Venture Partners, Insert Therapeutics, Inc., and Calando Pharmaceuticals, Inc. He serves as a director of companies such as LTC Properties Inc., Oncor Inc. and Health Management Inc. He serves as the Chairman of the Board of Directors of Novelix Pharmaceuticals Inc., which he founded in 2005. Dr. Triche received an A.B. from Cornell University in 1966, and in 1971, received both a Ph.D. in cell biology and an M.D. from Tulane University.
Timothy Triche, MD, ...
genomedx.com, 28 Nov 2013 [cached]
Timothy Triche, MD, PhD
Chairman and Chief Medical Officer
...
Timothy Triche, MD, PhD
Chairman and Chief Medical Officer
Dr. Timothy Triche is a board-certified anatomical and molecular pathologist and academic professor of pathology and laboratory medicine. Tim has built, operated and owned high-complexity molecular diagnostics testing laboratories for the past 30 years and runs the GenomeDx clinical laboratory. Previously, he was the director of Specialized Diagnostics and Section Chief for the Laboratory of Pathology at the National Cancer Institute before becoming Pathologist-in-Chief at Children's Hospital of Los Angeles and Vice-Chair for the Department of Pathology at the Keck School of Medicine at the University of Southern California. Currently, Tim is the director of the Center for Personalized Medicine at Children's Hospital Los Angeles and co-director of the Ronald A. Matriarcia Institute for Molecular Medicine at Phoenix Children's Hospital. He is a founding member of the Association for Molecular Pathology and has previously served as a senior executive in a number of medical companies, including founder and CEO of Oncomed Inc., which pioneered the use of hereditary genetic testing in oncology. Tim received in BSc in Physics at Cornell University, MD and PhD at Tulane Univeristy and completed his residency in anatomical pathology at Washington University School of Medicine. Tim's research in the field of applied genomics and the molecular biology of cancer has been recognized by numerous awards, grants and over 200 peer-reviewed publications. His goal in co-founding GenomeDx was to realize the promise of genomic technology towards improving the practice of cancer medicine.
...
Dr. Elai Davicioni trained as a pathobiologist in the genomics laboratory of Timothy Triche before becoming an entrepreneur, raising over $20M in grant funding and equity financing to launch GenomeDx.
Dr. Timothy Triche | PROOF Centre
www.proofcentre.ca, 3 Mar 2011 [cached]
Dr. Timothy Triche
...
Dr. Timothy Triche
...
Dr. Timothy Triche is Chief of the Department of Pathology at Children's Hospital Los Angeles and newly appointed Director of the Center for Personalized Medicine at CHLA. He also serves as Vice Chair, Department of Pathology and Professor of Pathology and Pediatrics at the Keck School of Medicine of the University of Southern California. Prior to joining Children's Hospital, Dr. Triche was Head of Molecular Diagnostics at the National Cancer Institute. He is a Beckman Fellow of the Beckman Macular Research Center at the Doheny Eye Institute, and serves on the Board of Directors of LTC Properties Corporation, GenomeDx, Nanovalent, and Novellix. He is also a standing member of NCI Subcommittees C, D, and E, and serves as Associate Chair for Translational Research in Children's Oncology Group. Professional memberships include the American Medical Association; United States and Canadian Academy of Pathology/Society for Pediatric Pathology; American Association for Cancer Research, and Association of Molecular Pathology (where he was a founding member of the solid tumor division). He also served as CEO and founder of OncorMed, a cancer predisposition company that developed several cancer predisposition tests, notably BRCA1 and 2, and several others.
He has been continuously NIH grant funded since joining USC/CHLA, including as PI on sequential NCI Director's Challenge and SPECS awards totalling over $15 million, and has published over 200 articles in the peer reviewed literature. He has also established numerous collaborations with emerging biotechnology companies, has helped develop clinical applications for key technologies like microarrays, and is currently supporting biomedical application development of single-molecule 'next gen' DNA sequencing. Since 2004, Dr. Triche has been voted by his peers as one of the "Best Doctors in America.
Officers & Directors
www.ltcproperties.com, 10 Jan 2014 [cached]
Timothy J. Triche, MD
Dr. Triche has been the Chairman of the Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private California-based biotechnology company and NanoValent Pharmaceuticals, Inc., a private nanotechnology company. Dr. Triche brings to the Board of LTC Properties, Inc. his experience as current and past executive and director experience with other health care companies, and his overall background in the health care industry.
Other People with the name "Triche":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304